Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Ram Vaidhyanath

Neuroradiology

View

Dr. Judith Gadde

Neuroradiology · Lurie Children's Hospital

View

Dr. Wende Gibbs

Neuroradiology · Barrow Neurological Institute

View

Dr. Daniel Gewolb

Neuroradiology · University of Miami

View

Dr. Sumir Patel

Neuroradiology · Emory University

View

Dr. Julie Bulman

Interventional Radiology · BIDMC

View

Dr. Monica Sheth

Breast Imaging · NYU Langone

View

Dr. Victoria Chernyak

Abdominal Imaging · CUIMC

View

Dr. Laura Hayes

Peds Radiology · Children's Healthcare of Atlanta

View

Dr. Amy Patel

Breast Imaging · UKHS

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    Posttreatment Follow-Up MR Imaging Biomarkers of Collateral Status Are Associated with Short-Term Outcomes in Large-Vessel Acute Ischemic Stroke.

    Mar 4, 2026DOI: 10.3174/ajnr.a9035Journal ArticleAJNR

    Written by: Cynthia GreeneAndrew ChoHamza Adel SalimDhairya A LakhaniTyler McGaugheyMeisam HoseinyazdiSijin WenJanet MeiJeremy J HeitTobias D FaizyGaurang ShahAakanksha SriwastwaYasmin AzizGregory W AlbersShyam MajmundarAdrien GuenegoAdam A DmytriwHanzhang LuArgye E HillisRafael LlinasRisheng XuRich LeighVivek Yedavalli

    Find these authors on Roon

    AS
    Dr. Aakanksha Sriwastwa
    Neuroradiology · UC

    Summary

    BACKGROUND AND PURPOSE: FLAIR hyperintense vessels (FHV), quantified using the National Institutes of Health (NIH)-FHV score (NFS), and the SWI brush sign (SBS) are MRI markers associated with hemodynamic impairment in acute ischemic stroke (AIS). We aimed to evaluate the prognostic significance of posttreatment NFS and SBS in patients with anterior circulation large-vessel occlusion (AIS-LVO), including those with successful reperfusion.MATERIALS AND METHODS: We retrospectively analyzed 273 patents with AIS-LVO with in-hospital follow-up MRI. NFS and SBS were evaluated and correlated with clinical outcomes including NIHSS shift (≥4-point improvement) and hemorrhagic transformation (HT). The Spearman correlation and logistic regression were performed, adjusting for clinical covariates. Analyses were repeated in the successfully reperfused subgroup of 181 cases (modified TICI [mTICI] ≥2b).RESULTS: FHV and the SBS were observed posttreatment in 38% and 20% of patients, respectively. NFS and SBS were positively correlated (ρ = 0.54, P < .01). NFS inversely correlated with NIHSS shift (ρ = -0.27, P < .01) and reperfusion grade (mTICI; ρ = -0.32, P < .01). NFS was independently associated with worse NIHSS shift (OR, 0.64; P < .01) and reduced odds of HT (OR, 0.76; P < .01). Among patients with successful reperfusion, 20% of mTICI 3 cases showed FHV. In this subgroup, NFS remained predictive of poor NIHSS shift (OR, 0.57; P = .01). SBS alone was not independently associated with outcomes.CONCLUSIONS: NFS on posttreatment MRI is a robust imaging biomarker of persistent perfusion deficits and early neurologic outcome, even after successful reperfusion. SBS may reflect complementary collateral dynamics but showed limited independent prognostic utility.
    ASDr. Aakanksha Sriwastwa

    Dr. Aakanksha Sriwastwa

    Radiology · Neuroradiology
    University of Cincinnati
    aakanksha